Serine/Threonine Kinase Pim-2 Promotes Liver Tumorigenesis Induction Through Mediating Survival and Preventing Apoptosis of Liver Cell

Journal of Surgical Research

Volumn 153, Issue 1, 2009, Pages 17-22

  Gong, Jianping ^a   Wang, Jinjing ^b   Ren, Ke ^a   Liu, Chang'an ^a   Li, Bo ^a   Shi, Yujun ^a,b  

^a Institute of Ultrasonic Engineering in Medicine   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

apoptosis; hepatocellular carcinoma; pim 2; tumorigenesis

Indexed keywords

INITIATION FACTOR 4E BINDING PROTEIN 1; INTERLEUKIN 3; PROTEIN BAD; PROTEIN KINASE PIM 2; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 63649150059     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.03.033     Document Type: Article

References (25)

1. Breuer M.L., Cuypers H.T., and Berns A. Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO J 8 (1989) 743
2. Fox C.J., Hammerman P.S., Cinalli R.M., et al. The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev 17 (2003) 1841
3. White E. The pims and outs of survival signaling: Role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. Genes Dev 17 (2003) 1813
4. Selten G., Cuypers H.T., Boelens W., et al. The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell 46 (1986) 603
5. van der Lugt N.M., Domen J., Verhoeven E., et al. Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J 14 (1995) 2536
6. Feldman J.D., Vician L., Crispino M., et al. KID-1, a protein kinase induced by depolarization in brain. J Biol Chem 273 (1998) 16535
7. Eichmann A., Yuan L., Breant C., et al. Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene 19 (2000) 1215
8. Allen J.D., Verhoeven E., Domen J., et al. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 15 (1997) 1133
9. Saris C.J., Domen J., and Berns A. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG. EMBO J 10 (1991) 655
10. Van Lohuizen M., Verbeek S., Krimpenfort P., et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56 (1989) 673
11. Fujii C., Nakamoto Y., Lu P., et al. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int J Cancer 114 (2005) 209
12. Eichmann A., Yuan L., Breant C., et al. Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene 19 (2000) 1215
13. Xu X.P., Li K.Z., Dou K.F., et al. Effect of coenzyme I on apoptosis of liver cell line L02 induced by ischemia-reperfusion injury. Di Yi Jun Yi Da Xue Xue Bao 22 (2002) 512
14. Kobayashi T., Ruan S., Clodi K., et al. Overexpression of Bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents. Oncogene 16 (1998) 1587
15. Xiao C., Qiu L., and Zen Q. Construction of shRNA targeted to the rat angiotensin II type 1 receptors and its RNAi in cytoplasma. J Huazhong Univ Sci Technol Med Sci 26 (2006) 4
16. Shen H.L., Xu W., Wu Z.Y., et al. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells. Leukoc Res 31 (2007) 515
17. Tsutsumi H., Kumagai T., Naitoo S., et al. Synthetic peptide (P-21) derived from Asp-hemolysin inhibits the induction of apoptosis on HUVECs by lysophosphatidylcholine. Biol Pharm Bull 29 (2006) 907
18. Zhang H., Brandt R., Heim J., et al. Mutations in FL5.12 cells conferring resistance to apoptosis induced by interleukin-3 deprivation. Int J Oncol 14 (1999) 113
19. Mizuki M., Schwable J., Steur C., et al. Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood 101 (2003) 3164
20. Hammerman P.S., Fox C.J., Birnbaum M.J., et al. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105 (2005) 4477
21. Chen W.W., Chan D.C., Donald C., et al. Pim family kinases enhance tumor growth of prostate cancer cells. Mol Cancer Res 3 (2005) 443
22. Dai H., Li R., Wheeler T., et al. Pim-2 upregulation: Biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate 65 (2005) 276
23. Ayala G.E., Dai H., Ittmann M., et al. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res 64 (2004) 6082
24. Yan B., Zemskova M., Holder S., et al. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem 278 (2003) 45358
25. Macdonald A., Campbell D.G., Toth R., et al. Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL. BMC Cell Biol 7 (2006) 1